Despite the setbacks of the past year, Canopy Growth (NYSE 🙂 (TSX :), the largest cannabis manufacturer, is still a pioneer in this relatively new industry that is constantly evolving. And shareholders tasted exactly that on Monday, when the company held its annual investor day.
The Ontario-based grower outlined his plan to focus on his "2.0 products", namely cannabis-based vaping and infused drinks, as a means to improve her financial position and the market share she has achieved lost years.
The urge to roll out cannabis-infused drinks is part of a marketing strategy for a customer base that is not interested in smoking. Business executives have reportedly said that it aims to reach customers looking for substitutes for alcohol.
NYSE Canopy Growth Shares
It's all part of Canopy's commitment to reviving investor interest and the range of poor, including the most recent report on the fourth quarter with a net loss of C $ 1.3 billion ($ 960 million).
Canopy also plans, as CEO David Klein put it, "making a lot of noise in the US," by increasing its activity in the US cannabidiol (CBD) market.
Canopy Growth's share gained just under 0.25% on the New York Stock Exchange yesterday, closed at US $ 17.37, but lost just over half a percentage point on the Toronto Stock Exchange and closed at C $ 23,465. So far, Canopy shares on the NYSE have lost 18% this year.
Charlotte & # 39; s Web Sinks After IPO Announcement
Shares of US-based CBD producer Charlotte & # 39; s Web Holdings (OTC 🙂 had rocketed their way up since last month, until the company announced last Tuesday it plans to raise C $ 67.5 million ($ 49.8 million) for a public offering in Canada. The funds are said to be used for business development and general working capital.
The stock fell more than 14% in New York by the end of that day and continued to fall, with another loss of 3.79% on Monday, ending at $ 4.43.
Charlotte & # 39; s Web Shares last month were supported by news that it had obtained a US patent for an improved variety of hemp. This is the company's second patent for hemp genetics, cementing its reputation as a leader in the CBD market.
Charlotte & # 39; s Web US Shares
In the last quarter, the company posted sales of $ 21.5 million. , much better than other CBD producers. The bad news continues to come for Hexo. Raise $ 5 million ($ 25.4 million) for a new stock offering.
Hexo shares were down 11% that day and were down for the rest of the week and through Monday, when they closed 2% lower at $ 0.738 in New York and fell 3% to C $ 0.99 in Toronto.
Jefferies analyst Owen Bennett was quoted as saying that the stock offering would dilute Hexo shares by about 5%.
